Quarterly report pursuant to Section 13 or 15(d)

REGISTERED DIRECT OFFERING 2017 (Details Textual)

v3.8.0.1
REGISTERED DIRECT OFFERING 2017 (Details Textual) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Mar. 03, 2017
Feb. 24, 2017
Feb. 20, 2017
Dec. 31, 2017
Dec. 31, 2016
Sep. 30, 2017
Sep. 30, 2016
Sep. 28, 2016
Sep. 30, 2013
Repayments of Notes Payable       $ 0 $ 228,594        
Derivative Liability   $ 2,996,110              
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)       $ 1,971,549 $ 0        
Common Stock [Member]                  
Stock Issued During Period, Shares, New Issues   10,166,664              
Massachusetts Life Sciences Center [Member]                  
Class of Warrant or Right, Exercise Price of Warrants or Rights                 $ 0.27
Qualified Financing, Minimum Net Proceeds               $ 5,000,000  
Repayments of Notes Payable $ 830,000                
REGISTERED DIRECT OFFERING 2017 [Member]                  
Shelf Registration Statement, Maximum Amount Authorized             $ 50,000,000    
Stock Issued During Period, Shares, New Issues     10,166,664            
Shares Issued, Price Per Share     $ 0.60            
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 0.75            
Stock Issued During Period, Value, New Issues   $ 6,100,000              
Number Of Warrants Per Unit     0.55            
Cash Price Per Each Common Stock Underlying Warrants   0.18              
Allocation Of Remaining Proceeds To Common Stock And Additional Paid In Capital   2,991,012              
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)           $ 433,923      
Payments of Stock Issuance Costs   112,000              
Percentage Of Class Of Warrant Or Right Held     0.00%            
REGISTERED DIRECT OFFERING 2017 [Member] | Series F Warrant [Member]                  
Stock Issued During Period, Value, New Issues   $ 5,987,122